Regulatory Expertise

Build Compliant Medical Software, Faster

CE Class IIb certified clinical decision support APIs. SNOMED-CT normalized, FHIR-native medication database. Posos carries the CE marking for the most critical components of your prescription modules, so you can focus on your product.
15+ integrated software vendors
2 CE IIb marked medical devices
ISO 13485 certified
Integration in 2–4 weeks
The challenge

Regulatory Barriers Slowing Down Your Product Roadmap

Achieving regulatory compliance for clinical decision support software ties up your teams for 18–24 months, delays your roadmap, and postpones market entry.

Drug-Drug Interaction

Identifies and manages risks with combining multiple medications.

Drug Condition Interaction or Disease Contraindication

Alerts on medication risks in specific medical conditions.

Adverse Effects

Comprehensive list of drug side effects, including frequency and severity.

Dose Range Check Dosing

Validates medication doses within safe, effective ranges.

Geriatric

Specialized drug use considerations for geriatric patients.

Order Entry

Streamlines prescription input, ensuring accuracy and efficiency.

Monographs

Detailed drug profiles with clinical data and usage guidelines.

Customized Alternatives

Tailored drug options based on patient existing treatments and comorbidities.

Pregnancy

Evaluates and advises on drug use and risks during pregnancy.
Coming soon

Allergy

Detects and warns of potential allergic reactions to drugs.
Coming soon

Duplicate Therapy

Flags overlapping therapies, preventing redundant drug prescriptions.

Complex MDR Conformity Assessment

  • Notified Body certification required for Class IIb
  • 18–24 months typical timeline
  • €200K+ investment
  • Dedicated regulatory resources

Expanding to New Markets

  • Each new country requires a complete local medication database from scratch
  • Local coding systems (CNK, SAM, CIF...) differ from one market to the next
  • Keeping up with medication approvals, withdrawals, and price changes across multiple countries
  • Clinical guidelines and dosage rules vary by country, and evolve constantly

Interoperability & Standards Compliance

  • FHIR R4 increasingly required by health authorities
  • SNOMED-CT adoption mandated in growing number of EU countries
  • Mapping legacy proprietary codes to international standards is costly and error-prone
Our regulatory partnership

Posos Handles the Most Critical Components of Your Compliance

Drug-drug interactions. Drug-disease interactions. Dosage control. Tailored treatment and dosage suggestions. We carry the CE marking — you focus on your product.

Drug-Drug Interaction

Identifies and manages risks with combining multiple medications.

Drug Condition Interaction or Disease Contraindication

Alerts on medication risks in specific medical conditions.

Adverse Effects

Comprehensive list of drug side effects, including frequency and severity.

Dose Range Check Dosing

Validates medication doses within safe, effective ranges.

Geriatric

Specialized drug use considerations for geriatric patients.

Order Entry

Streamlines prescription input, ensuring accuracy and efficiency.

Monographs

Detailed drug profiles with clinical data and usage guidelines.

Customized Alternatives

Tailored drug options based on patient existing treatments and comorbidities.

Pregnancy

Evaluates and advises on drug use and risks during pregnancy.
Coming soon

Allergy

Detects and warns of potential allergic reactions to drugs.
Coming soon

Duplicate Therapy

Flags overlapping therapies, preventing redundant drug prescriptions.

CE Class IIb Certified APIs

  • EU MDR 2017/745 CE marking in place
  • ISO 13485 certified Quality Management System
  • Documentation ready for your regulatory file

Multi-Country Medication Coverage

  • Complete local formulary for each country: all medications, all dosage forms
  • Local coding systems natively supported (CNK for Belgium, CIF for Luxembourg...)
  • Continuous updates: new molecules, withdrawals, price changes — managed by Posos
  • Currently live: France, Belgium, Luxembourg.

Native Interoperability

  • 100% SNOMED-CT normalized database
  • FHIR R4 native APIs, CDS Hooks compatible
  • Multi-terminology structuring: ICD-10/11, ATC, EDQM, UCUM, UNII
  • No manual mapping required

Auditable Clinical Reasoning

  • Medical knowledge graph connects medications, pathologies, and guidelines
  • Every recommendation is fully traceable
  • Deterministic algorithms ensure reproducibility — down to dose calculation
  • Architecture aligned with upcoming transparency requirements for medical AI
Why integrate Posos?

What Posos Changes for Your Compliance Roadmap

CE Conformity
Medication Database
Interoperability
Maintenance
AI Agents
With
CE IIb certified APIs ready to integrate. Posos carries the CE marking for clinical analysis components.
SNOMED-CT normalized. Multi-country. Local coding systems included. Continuously updated by Posos.
Native FHIR R4 APIs. CDS Hooks compatible. SNOMED-CT, ICD-10/11, ATC out of the box.
Continuous updates by Posos. Regulatory watch included. You're alerted when action is needed on your side.
Certified APIs consumable by your AI agents. Deterministic, auditable outputs.
Without Posos
18–24 months internal work. Notified Body process. €200K+ investment.
Integrate third-party databases. Manual mappings. Proprietary formats. No standardization.
Costly custom integrations. Complex manual mappings to international standards.
Your team handles: new molecules, regulatory changes, guideline updates, country expansions.
No certified abstraction layer. Risk of hallucination on clinical data.
Données patient
Normalisées SNOMED-CT, FHIR, ICD-10/11.
Champs texte libre, formats propriétaires, silos.
Suggestions thérapeutiques
Issues d'un graphe de connaissances médicales, chaque recommandation est sourcée et traçable.
Générées par LLM, non auditables.
Conformité
API certifiées CE IIb prêts à l'emploi, conformité LAP V2 accélérée.
Roadmap interne de 36+ mois pour être certifié LAP V2 et CE IIb.
Intéropérabilité
API modernes FHIR et CDS Hooks natifs, récupération et retranscription de l’historique patient par modèles IA propriétaires.   
Intégrations sur mesure coûteuses et longues, nécessitant des mappings manuels complexes et imparfaits.
Agents IA
Source d’informations médicales validées et structurée via des APIs certifiées.
Risque d’accès à du contexte non vérifié, risque d'hallucination.
Proven at scale

Proprietary Technology, Certifications That Matter

Frequently Asked Questions

Contact-us
What is Posos's role in my CE marking process?

Posos acts as Legal Manufacturer under EU MDR 2017/745 for its own medical devices. Our clinical analysis APIs — covering drug-drug interactions, drug-disease interactions, dosage control, and treatment suggestions — are Class IIb medical devices already CE marked. They constitute integrable components for your clinical decision support modules.

When you integrate Posos solutions (Widget or APIs), Posos carries the CE marking responsibility for these software components.

What is my role as integrator?

By integrating and distributing Posos solutions already CE marked, you become a Distributor under EU MDR 2017/745 (Article 14). As a Distributor, your regulatory obligations are significantly lighter than those of a Manufacturer: you verify that the CE marking is in place, ensure proper storage and transport conditions, and forward any incident reports to the Manufacturer, but you do not need to manage the conformity assessment process for the Posos components.

If your complete software product independently qualifies as a medical device, you will need your own CE marking. However, by integrating Posos, your entire prescription analysis module is already covered: drug-drug interactions, drug-disease interactions, dosage control, treatment suggestions, and therapeutic alternatives. This significantly reduces the scope of your own conformity assessment to the parts of your product outside of prescription analysis.

What clinical functions are covered by the CE IIb marking?

The CE marking covers our APIs for:
  - Drug-drug interaction detection
  - Drug-disease interaction detection
  - Dosage analysis (overdose, underdose, duration)
  - Treatment and dosage suggestions
  - Therapeutic alternative recommendations

Medication search, editing, and database browsing functions are not medical devices.

What happens in case of regulatory changes?

Posos maintains continuous regulatory surveillance and keeps its medical devices compliant with applicable requirements: MDR amendments, MDCG guidance, standards amendments, and evolving interoperability mandates. When impactful changes occur, we update our products and alert you if actions are needed on your side.

How are responsibilities managed in case of a clinical error?

Medical responsibility remains with the prescribing healthcare professional. Posos is responsible for the conformity and proper functioning of its clinical decision support modules deployed in your software. Our contracts clearly define responsibility boundaries.

Is Posos compatible with my technical stack?

Yes. Posos offers 2 integration modes: GraphQL APIs (to keep 100% of your interface) or widgets (for rapid integration with ready-made interfaces). Our widgets integrate into any application architecture — no specific framework dependency required (no mandatory React version, for example). Our APIs are language-agnostic and support healthcare interoperability standards (FHIR R4, SNOMED-CT, CDS Hooks).

What about UK market access?

CE marking is currently accepted in Great Britain under transitional arrangements (until 2028–2030 depending on device type). Posos is registered with the MHRA and holds the required certification for the UK market. We provide documentation aligned with UK MDR 2002 requirements and support your UK Responsible Person obligations and MHRA registration. See our FAQ for details.

How does Posos's approach differ from pure AI / LLM-based solutions?

Posos uses deterministic algorithms based on a structured medical knowledge graph — not probabilistic LLM inference. Every recommendation traces through documented medical logic, making it fully auditable. This architecture is inherently aligned with the transparency and explainability expectations emerging from EU medical AI regulations.

Accelerate Your Regulatory Compliance

Talk to our regulatory experts to assess your context and define the best integration strategy for EU market access.